151
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of TyG Index with CT Features in Patients with Tuberculosis and Diabetes Mellitus

ORCID Icon, , , , , , , , , & show all
Pages 111-125 | Published online: 12 Jan 2022

References

  • Organization WH. Health at a glance: Asia/Pacific; 2020. Available from: https://www.oecd-ilibrary.org/content/publication/26b007cd-en. Accessed December 11, 2020.
  • WHO. Global tuberculosis report; 2021. Available from: https://www.who.int/publications/digital/global-tuberculosis-report-2021. Accessed December 31, 2021.
  • Marais BJ, Lönnroth K, Lawn SD. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts - ScienceDirect. Lancet Infect Dis. 2013;13(5):436–448. doi:10.1016/S1473-3099(13)70015-X
  • Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: a systematic review and meta-analysis. PLoS One. 2017;12(11):e0187967. doi:10.1371/journal.pone.0187967
  • Amare H, Gelaw A, Anagaw B, Gelaw B. Smear positive pulmonary tuberculosis among diabetic patients at the Dessie referral hospital, Northeast Ethiopia. Infect Dis Poverty. 2013;2(1):6. doi:10.1186/2049-9957-2-6
  • Hayashi S, Chandramohan D. Risk of active tuberculosis among people with diabetes mellitus: systematic review and meta-analysis. Trop Med Int Health. 2018;23(10):1058–1070. doi:10.1111/tmi.13133
  • Workneh MH, Bjune GA, Yimer SA, Wilkinson KA. Prevalence and associated factors of tuberculosis and diabetes mellitus comorbidity: a systematic review. PLoS One. 2017;12(4):e0175925. doi:10.1371/journal.pone.0175925
  • WHO. Global Tuberculosis Report; 2018.
  • Chumburidze-Areshidze N, Kezeli T, Avaliani Z, Mirziashvili M, Avaliani T, Gongadze N. The relationship between type-2 diabetes and tuberculosis. Georgian Med News. 2020;300:69–74.
  • Philips L, Visser J, Nel D, Blaauw R. The association between tuberculosis and the development of insulin resistance in adults with pulmonary tuberculosis in the Western sub-district of the Cape Metropole region, South Africa: a combined cross-sectional, cohort study. BMC Infect Dis. 2017;17(1):570. doi:10.1186/s12879-017-2657-5
  • Odegaard JI, Chawla A. Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis. Science. 2013;339(6116):172–177. doi:10.1126/science.1230721
  • Fiorentino TV, Marini MA, Succurro E, Andreozzi F, Sesti G. Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage. BMJ Open Diabetes Res Care. 2019;7(1):e000911. doi:10.1136/bmjdrc-2019-000911
  • Guerrero-Romero F, Simental-Mendia LE, Gonzalez-Ortiz M, et al. The product of triglycerides and glucose, a simple measure of insulin sensitivity. Comparison with the euglycemic-hyperinsulinemic clamp. J Clin Endocrinol Metab. 2010;95(7):3347–3351. doi:10.1210/jc.2010-0288
  • Angoorani P, Heshmat R, Ejtahed HS, et al. Validity of triglyceride–glucose index as an indicator for metabolic syndrome in children and adolescents: the CASPIAN-V study. Eat Weight Disord. 2018;23(6):877–883. doi:10.1007/s40519-018-0488-z
  • Hong S, Han K, Park CY. The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. BMC Med. 2020;18(1):361. doi:10.1186/s12916-020-01824-2
  • Silva AD, Caldas A, Rocha D, Bressan J. Triglyceride-glucose index predicts independently type 2 diabetes mellitus risk: a systematic review and meta-analysis of cohort studies. Prim Care Diabetes. 2020;14(6):584–593. doi:10.1016/j.pcd.2020.09.001
  • Wang Y, Yang W, Jiang X. Association between triglyceride-glucose index and hypertension: a meta-analysis. Front Cardiovasc Med. 2021;8:644035. doi:10.3389/fcvm.2021.644035
  • Yang WB, Wang HL, Mao JT, et al. The correlation between CT features and insulin resistance levels in patients with T2DM complicated with primary pulmonary tuberculosis. J Cell Physiol. 2020;235(12):9370–9377. doi:10.1002/jcp.29741
  • He L. Oral Hypoglycemic Agents. Ellenberg and Rifkins’s Diabetes Mellitus, Theory and Practice. 4th ed. Vol. 1990. Elsevier; 1990:554–574.
  • Atkin SL, Masson EA, Bodmer CW, Walker BA, White MC. Increased insulin requirement in a patient with type 1 diabetes on rifampicin. Diabet Med. 1993;10(4):392. doi:10.1111/j.1464-5491.1993.tb00086.x
  • Niazi AK, Kalra S. Diabetes and tuberculosis: a review of the role of optimal glycemic control. J Diabetes Metab Disord. 2012;11(1):28. doi:10.1186/2251-6581-11-28
  • Madsbad S. Treatment of type 2 diabetes with incretin-based therapies. Lancet. 2009;373(9662):438–439. doi:10.1016/S0140-6736(08)61247-7
  • AD American Diabetes Association. 2. classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl1):S15–S33. doi:10.2337/dc21-S002
  • Joint Committee for Developing. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhong Hua Xin Xue Guan Bing Za Zhi. 2007;35(5):390.
  • Gadkowski LB, Stout JE. Cavitary pulmonary disease. Clin Microbiol Rev. 2008;21(2):305–333. doi:10.1128/CMR.00060-07
  • Mlinar B, Marc J, Janež A, Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta. 2007;375(1–2):20–35. doi:10.1016/j.cca.2006.07.005
  • Vasques A, Novaes FS, Oliveira M, et al. TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study. Diabetes Res Clin Pract. 2011;93(3):e98–e100. doi:10.1016/j.diabres.2011.05.030
  • Xia LL, Li SF, Shao K, Xin Z, Huang SJI, Resistance D. The correlation between CT features and glycosylated hemoglobin level in patients with T2DM complicated with primary pulmonary tuberculosis. Infect Drug Resist. 2018;11:187–193. doi:10.2147/IDR.S146741
  • Im JG, Song KS, Kang HS, et al. Mediastinal tuberculous lymphadenitis: CT manifestations. Radiology. 1987;164(1):115–119. doi:10.1148/radiology.164.1.3588896
  • Leung AN. Pulmonary tuberculosis: the essentials. Radiology. 1999;210(2):307–322. doi:10.1148/radiology.210.2.r99ja34307
  • Lin PL, Maiello P, Gideon HP, et al. PET CT identifies reactivation risk in cynomolgus macaques with latent M. tuberculosis. PLoS Pathog. 2016;12(7):e1005739. doi:10.1371/journal.ppat.1005739
  • Bloomgarden Z, Misra A. Diabetes and tuberculosis: an important relationship. J Diabetes. 2017;9(7):640–643. doi:10.1111/1753-0407.12547
  • Kumar NP, Moideen K, Bhootra Y, et al. Elevated circulating levels of monocyte activation markers among tuberculosis patients with diabetes co-morbidity. Immunology. 2019;156(3):249–258. doi:10.1111/imm.13023
  • Kim J, Lee IJ, Kim JH. CT findings of pulmonary tuberculosis and tuberculous pleurisy in diabetes mellitus patients. Diagn Interv Radiol. 2017;23(2):112–117. doi:10.5152/dir.2016.16157
  • Markus M, Rospleszcz S, Ittermann T, et al. Glucose and insulin levels are associated with arterial stiffness and concentric remodeling of the heart. Cardiovasc Diabetol. 2019;18(1):145. doi:10.1186/s12933-019-0948-4
  • McGarry J, Diabetes DJ. Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes Care. 2002;5(1):7–18. doi:10.2337/diabetes.51.1.7
  • Dong Z, Shi J, Dorhoi A, et al. Hemostasis and lipoprotein indices signify exacerbated lung injury in TB with diabetes comorbidity. Chest. 2018;153(5):1187–1200. doi:10.1016/j.chest.2017.11.029
  • Kager LM, Blok DC, Lede IO, et al. Pulmonary tuberculosis induces a systemic hypercoagulable state. J Infect. 2015;70(4):324–334. doi:10.1016/j.jinf.2014.10.006
  • Deniz O, Gumus S, Yaman H, et al. Serum total cholesterol, HDL-C and LDL-C concentrations significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis. Clin Biochem. 2007;40(3–4):162–166. doi:10.1016/j.clinbiochem.2006.10.015
  • Cardona PJJC, Immunology D. A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosis. Clin Dev Immunol. 2011;2011:1–9. doi:10.1155/2011/868246
  • Hunter RL, Jagannath C, Actor JK. Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis. 2007;87(4):267–278. doi:10.1016/j.tube.2006.11.003
  • Mercer PF, Chambers RC. Coagulation and coagulation signalling in fibrosis. Biochim Biophys Acta. 2013;1832(7):1018–1027. doi:10.1016/j.bbadis.2012.12.013
  • Qu Z, Chaikof EL. Interface between hemostasis and adaptive immunity. Curr Opin Immunol. 2010;22(5):634–642. doi:10.1016/j.coi.2010.08.017
  • Han T, Cheng Y, Tian S, et al. Changes in triglycerides and high-density lipoprotein cholesterol may precede peripheral insulin resistance, with 2-h insulin partially mediating this unidirectional relationship: a prospective cohort study. Cardiovasc Diabetol. 2016;15(1):154. doi:10.1186/s12933-016-0469-3
  • Berrington WR, Hawn TR. Mycobacterium tuberculosis, macrophages, and the innate immune response: does common variation matter? Immunol Rev. 2010;219(1):167–186. doi:10.1111/j.1600-065X.2007.00545.x
  • Giannini C, Santoro N, Caprio S, et al. The triglyceride-to-HDL cholesterol ratio: association with insulin resistance in obese youths of different ethnic backgrounds. Diabetes Care. 2011;34(8):1869–1874. doi:10.2337/dc10-2234
  • Hmp A, Hsl B, Yjl C, Jhl DJDR, Practice C. The triglyceride–glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance. Diabetes Res Clin Pract. 2021;180:109042. doi:10.1016/j.diabres.2021.109042
  • Zwa C, Jw A, Zl A, et al. Triglyceride glucose index and carotid atherosclerosis incidence in the Chinese population: a prospective cohort study. Nutr Metab Cardiovasc Dis. 2021;31(7):2042–2050. doi:10.1016/j.numecd.2021.03.027